209 related articles for article (PubMed ID: 37973557)
1. Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.
Sun H; Sun L; Ke X; Liu L; Li C; Jin B; Wang P; Jiang Z; Zhao H; Yang Z; Sun Y; Liu J; Wang Y; Sun M; Pang M; Wang Y; Wu B; Zhao H; Sang X; Xing B; Yang H; Huang P; Mao Y
Adv Sci (Weinh); 2024 Jan; 11(2):e2304460. PubMed ID: 37973557
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy.
Mo S; Tang P; Luo W; Zhang L; Li Y; Hu X; Ma X; Chen Y; Bao Y; He X; Fu G; Xu X; Rao X; Li X; Guan R; Chen S; Deng Y; Lv T; Mu P; Zheng Q; Wang S; Liu F; Li Y; Sheng W; Huang D; Hu C; Gao J; Zhang Z; Cai S; Clevers H; Peng J; Hua G
Adv Sci (Weinh); 2022 Nov; 9(31):e2204097. PubMed ID: 36058001
[TBL] [Abstract][Full Text] [Related]
3. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
[TBL] [Abstract][Full Text] [Related]
4. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
5.
Zhang MY; Zhang RJ; Jiang HJ; Jiang H; Xu HL; Pan WB; Wang YQ; Li X
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):164-172. PubMed ID: 30850340
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.
Rompianesi G; Pegoraro F; Ceresa CD; Montalti R; Troisi RI
World J Gastroenterol; 2022 Jan; 28(1):108-122. PubMed ID: 35125822
[TBL] [Abstract][Full Text] [Related]
8. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
[TBL] [Abstract][Full Text] [Related]
11. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.
Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH
Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868
[No Abstract] [Full Text] [Related]
12. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.
Zhao S; Mi Y; Guan B; Zheng B; Wei P; Gu Y; Zhang Z; Cai S; Xu Y; Li X; He X; Zhong X; Li G; Chen Z; Li D
J Hematol Oncol; 2020 Nov; 13(1):156. PubMed ID: 33213490
[TBL] [Abstract][Full Text] [Related]
13. Personalized treatment in patients with colorectal liver metastases.
Moris D; Pawlik TM
J Surg Res; 2017 Aug; 216():26-29. PubMed ID: 28807210
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
[TBL] [Abstract][Full Text] [Related]
15. Disruption of clock gene expression in human colorectal liver metastases.
Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine.
Xie F; Sun L; Pang Y; Xu G; Jin B; Xu H; Lu X; Xu Y; Du S; Wang Y; Feng S; Sang X; Zhong S; Wang X; Sun W; Zhao H; Zhang H; Yang H; Huang P; Mao Y
Biomaterials; 2021 Jan; 265():120416. PubMed ID: 33007612
[TBL] [Abstract][Full Text] [Related]
17. An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.
Zhou X; Qian Y; Ling C; He Z; Shi P; Gao Y; Sui X
J Transl Med; 2024 Mar; 22(1):321. PubMed ID: 38555418
[TBL] [Abstract][Full Text] [Related]
18. Significant association of MCP1 rs1024611 and CCR2 rs1799864 polymorphisms with colorectal cancer and liver metastases susceptibility and aggressiveness: A case-control study.
Boughriba R; Sahraoui G; Chaar I; Weslati M; Ayed K; Ounissi D; Hazgui M; Bouraoui S; Gati A
Cytokine; 2023 Jul; 167():156193. PubMed ID: 37149962
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
Vellinga TT; Kranenburg O; Frenkel N; Ubink I; Marvin D; Govaert K; van Schelven S; Hagendoorn J; Borel Rinkes IH
Ann Surg; 2017 Nov; 266(5):765-771. PubMed ID: 28742689
[TBL] [Abstract][Full Text] [Related]
20. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
